USF Health, Weill Cornell Medicine Earn Inaugural Funding in NIH’s Newly Launched Bridge2AI Initiative, will Create Artificial Intelligence Platform for Using Voice to Diagnose Disease. As one of four projects funded by NIH’s Bridge2AI, this...
Read more
6 Biotech Breakthroughs of 2021 That Missed the Attention They Deserved News about COVID-19 continues to relentlessly dominate as Omicron surges around the globe. Yet somehow, during the pandemic’s exhausting twists and turns, progress in...
Read more
New York Study Aims to Assess Utility of Clinical Whole-Genome Sequencing Across Diseases NEW YORK – A clinical research study recently launched by researchers at Weill Cornell Medicine, New York Presbyterian, and the New York Genome Center, with ...
Read more
We hope you enjoy this local CBS News story, “Researchers Growing Miniature Human Brains In Search For Pediatric Brain Tumor Treatment,” shot in part at the Englander Institute for Precision Medicine and featuring EIPM Member and...
Read more
In recognition of May’s designation as National Cancer Research Month, EIPM Director Olivier Elemento, Ph.D. shares his thoughts on the state of precision medicine in creating next-generation treatment for cancer. Please click on the link...
Read more
How a patient and her doctor used precision medicine to fight aggressive uterine cancer. From NewYork-Presbyterian’s Health Matters When Ronda Kotelchuck learned she had an aggressive form of uterine cancer, she was frightened and anxious...
Read more
Jenny Zhaoying Xiang, M.D., is a Member of the Englander Institute for Precision Medicine, Director of the Genomics Resources Core Facility (GRCF), Professor of Research in Microbiology and Immunology at Weill Cornell Medicine, and a faculty...
Read more
Introducing Wael Al Zoughbi, M.D., Ph.D., the newest Member of the Englander Institute for Precision Medicine and a Research Pathology Fellow in Precision Medicine. He recently came to the United States from Austria, where he earned his Ph.D. in...
Read more
WE’RE THRILLED TO WELCOME MELISSA B. DAVIS, PH.D., TO THE ENGLANDER INSTITUTE FOR PRECISION MEDICINE TEAM. DR. DAVIS IS A MOLECULAR GENETICIST, AND HER RESEARCH INTERESTS INCLUDE GENOMICS AND SYSTEMS BIOLOGY. Dr. Davis is Assistant Professor of...
Read more
The US Food and Drug Administration last month granted accelerated approval to a new cancer drug for adult and pediatric patients with solid tumors that have a specific genetic mutation detectable through Oncomine Comprehensive, an advanced Next...
Read more
The Englander Institute for Precision Medicine’s (EIPM) Symposium fueled innovation and collaboration, bringing together nearly 200 faculty, students, and research staff last Thursday, November 15th. The inaugural event, “Innovations and Emerging ...
Read more
TO CONCLUDE OUR RECOGNITION OF OCTOBER’S NATIONAL BREAST CANCER AWARENESS MONTH, WE’RE VERY HAPPY TO HIGHLIGHT DR. KRISTY BROWN’S RESEARCH THAT EXPLORES WHY OBESE WOMEN ARE AT HIGHER RISK OF DEVELOPING BREAST CANCER. Kristy A. Brown...
Read more